Skip to main content

Schuyler Kevin

In the past year, 1 open-market purchase filing worth $10.2K and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$10.2K
1 filing
Sold
–
0 filings
Net
+$10.2K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Schuyler Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

VEEE Twin Vee PowerCats, Co.

Director2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 19, 2026 (view filing)5:01 PM ETMar 19Same daySchuyler KevinDirectorPPurchase+25.0K$0.4066+$10.2K+399.9%31.3K after
Dec 22, 2022 (view filing)Dec 21-221 daySchuyler KevinDirectorPPurchase+1.36K$1.78+$2.43KNew position1.36K after2 lots

FRZA Forza X1, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 18, 2024 (view filing)8:00 AM ETSep 171 daySchuyler KevinDirectorPPurchase+90.7K$0.30+$27.2K+971.6%100.0K after
Dec 22, 2022 (view filing)Dec 22Same daySchuyler KevinDirectorPPurchase+5.00K$1.14+$5.70K+115.4%9.33K after
Dec 21, 2022 (view filing)Dec 201 daySchuyler KevinDirectorPPurchase+4.33K$1.20+$5.20KNew position4.33K after

ADIL Adial Pharmaceuticals, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 3, 2023 (view filing)Sep 294 daysSchuyler KevinDirectorPPurchase+700$2.74+$1.92KNew position700 after